Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lung Cancer

Clinical Trial at: Comprehensive Cancer Centers of Nevada - Las Vegas

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

9280 W Sunset Rd, Suite 100
Las Vegas, NV 89148
P: (702) 952-1251

More Details View Practice Page

Lung Cancer

Clinical Trial at: 19193-Lung Cancer-NA-987 -

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details


,
P:

More Details View Practice Page

Lung Cancer

Clinical Trial at: 19193-Lung Cancer-NA-632 -

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details


,
P:

More Details View Practice Page

Lung Cancer

Clinical Trial at: 19193-Lung Cancer-NA-1553 -

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details


,
P:

More Details View Practice Page

Lung Cancer

Clinical Trial at: Comprehensive Cancer Centers of Nevada - Henderson

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

1505 Wigwam Pkwy, Suite 130
Henderson, NV 89074
P: (702) 856-1400

More Details View Practice Page

Lung Cancer

Clinical Trial at: Virginia Cancer Specialists - Gainesville

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

7901 Lake Manassas Dr
Gainesville, VA 20155
P: (571) 222-2200

More Details View Practice Page

Lung Cancer

Clinical Trial at: 19193-Lung Cancer-NA-1044 -

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details


,
P:

More Details View Practice Page

Lung Cancer

Clinical Trial at: Comprehensive Cancer Centers of Nevada - Las Vegas

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

7445 Peak Dr
Las Vegas, NV 89128
P: (702) 952-2140

More Details View Practice Page

Lung Cancer

Clinical Trial at: 19193-Lung Cancer-NA-1045 -

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details


,
P:

More Details View Practice Page

Lung Cancer

Clinical Trial at: Virginia Cancer Specialists - Fairfax

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

8503 Arlington Blvd, Suite 400
Fairfax, VA 22031
P: (703) 280-5390

More Details View Practice Page